-
1 Comment
LanZhou Foci Pharmaceutical Co.,Ltd is currently in a long term uptrend where the price is trading 18.3% above its 200 day moving average.
From a valuation standpoint, the stock is 42.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.5.
LanZhou Foci Pharmaceutical Co.,Ltd's total revenue rose by 11.5% to $174M since the same quarter in the previous year.
Its net income has dropped by 62.8% to $11M since the same quarter in the previous year.
Finally, its free cash flow fell by 188.9% to $-61M since the same quarter in the previous year.
Based on the above factors, LanZhou Foci Pharmaceutical Co.,Ltd gets an overall score of 3/5.
CurrencyCode | CNY |
---|---|
ISIN | CNE1000019W4 |
Industry | Drug Manufacturers-Specialty & Generic |
Sector | Healthcare |
Exchange | SHE |
Target Price | None |
---|---|
Market Cap | 6B |
Beta | 0.13 |
PE Ratio | 59.19 |
Dividend Yield | 0.1% |
LanZhou Foci Pharmaceutical Co.,Ltd., a pharmaceutical company, manufactures and sells traditional Chinese medicines in China. It offers its products in various dosage forms, including pills, tablets, capsules, and granules under the Min Shan and Foci brands. The company also engages in researching activities for the development of new herbal drugs. It also exports its products to approximately 27 countries, which include the United States, Canada, Japan, Australia, Russia, Ukraine, Singapore, Indonesia, Thailand, Malaysia, New Zealand, Hong Kong, etc. The company was founded in 1929 and is based in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. is a subsidiary of Lanzhou Foci Pharmaceutical Factory.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002644.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024